Murexins Sustained-release Tablets (Eperisone Hydrochloride)

Adult dose

This medication is a sustained-release tablet and should be taken whole without crushing, dividing, or chewing. Adults typically take 1 tablet (75 mg of Eperisone Hydrochloride) orally twice daily after meals. Adjustments may be made according to age and symptoms.

This medication should not be administered to certain patients. For example, it should not be used in patients with an allergy to this drug or those suffering from myasthenia gravis. In addition, it should be used with caution in patients with a history of allergy to the drug or those with liver dysfunction, as liver function may deteriorate. While taking this medication, serious allergic reactions may rarely occur. If symptoms such as redness, itching, hives, swelling, or difficulty breathing appear, immediately discontinue use and seek medical help. Additionally, symptoms of serious skin conditions such as toxic epidermal necrolysis or Stevens-Johnson syndrome may occur, so symptoms like fever, erythema, blisters, itching, conjunctival injection, and stomatitis should be closely monitored. Liver enzyme levels may occasionally rise, or there may be abnormalities in kidney function, so regular check-ups are recommended. This medication may cause various side effects such as dizziness, headache, drowsiness, nausea, vomiting, loss of appetite, constipation, diarrhea, and abdominal pain. If these symptoms are severe, consult a physician. During treatment, fatigue, staggering, and drowsiness may occur, so if these symptoms arise, it is necessary to reduce or discontinue the dosage. This medication may cause drowsiness and decreased attention, so it is advisable to avoid driving or operating hazardous machinery. There may be interactions when used with other medications, especially with medications containing similar ingredients, so it is essential to consult a doctor or pharmacist. Women who are pregnant or might become pregnant should use this medication only when the benefits outweigh the risks. If breastfeeding, it is advisable to avoid the medication, and if unavoidable, breastfeeding should be discontinued. Safety for children has not been sufficiently established, so it should be administered to children with caution. Elderly patients may have decreased bodily functions, so attention is required to adjust drug dosage.

Serious side effects

• Hives
• swelling
• difficulty breathing
• redness
• itching
• shock
• anaphylactic reaction
• toxic epidermal necrolysis
• Lyell syndrome
• mucocutaneous syndrome

Mild side effects

• Nausea
• vomiting
• loss of appetite
• abdominal discomfort
• thirst
• constipation
• diarrhea
• abdominal pain
• abdominal bloating
• stomatitis

This medication may be sensitive to air and humidity, so it should be stored in a tightly sealed container. It is recommended to maintain the storage temperature between 1 °C and 30 °C at room temperature. Proper storage will ensure the safe retention of the medication's effectiveness.

Appearance

White to almost white round sustained-release film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle